EFFICIENCY OF THERAPY FOR SEASONAL ACUTE RESPIRATORY DISEASES IN PATIENTS WITH COMORBIDITIES

Download full text PDF
Issue: 
3
Year: 
2017

V. Shishkova, Candidate of Medical Sciences; L. Zotova Center for Speech Pathology and Neurorehabilitation, Moscow

In the structure of seasonal death rates in adults and children, there is a predominance of acute respiratory infections (ARI) of different etiologies, which occur with the involvement of the upper respiratory tract (URT), trachea, and bronchi and have a certain similarity in the development of pathogenesis and clinical symptoms. The paper gives the results of studying the clinical efficiency and safety of Oscillococcinum therapy for ARI with URT involvement in patients with comorbidities versus symptomatic therapy.

Keywords: 
therapy
upper respiratory tract
acute respiratory infections
comorbidities



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. The world health report 2002 – Reducing Risks, Promoting Healthy Life // World Health Organization. – 2002; 186: 192.
  2. Zabolevaemost' naselenija Rossii v 2007 godu. Statisticheskie materialy / M., 2008.
  3. Shishkova V.N. Komorbidnost' i poliprogmazija: fokus na tsitoprotektsiju // Consilium Medicum. – 2016; 18 (12): 65–71.
  4. Boyd C. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for performance // JAMA. – 2005; 294 (6): 716–24.
  5. Caughey G., Vitry A., Cibert A. Prevalence of comorbidity of chronic diseases in Australia // BMC Public Health. – 2008; 8: 221.
  6. Charlson M., Pompei P., Ales H. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation // J. Chron. Dis. – 1987; 40: 373–83.
  7. Shishkova V.N. Effektivnost', bezopasnost' i neopravdannaja polipragmazija v lechenii ostryh respiratornyh zabolevanij // Vrach. – 2016; 11: 50–3.
  8. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation, 2011
  9. Dedov I.I., Shestakova M.V. Saharnyj diabet / M.: Meditsinskoe informatsionnoe agentstvo, 2005; 677 s.
  10. Shishkova V.N. Osobennosti sovremennoj komorbidnoj patologii i vozmozhnosti korrektsii v praktike terapevta // Poliklinika (spetsvyp. Nevrologija). – 2016; 1: 58–65.
  11. Shishkova V.N. Saharnyj diabet kak predraspolagajuschaja k razvitiju respiratornyh zabolevanij patologija // Vrach. – 2013; 11: 25–8.
  12. Chin-Hong P. Infections in patients with diabetes mellitus: importance of early recognition? Treatment and prevention // Adv. Stud. Med. – 2006; 6 (2): 71–81.
  13. Shishkova V.N. Vozmozhnosti sovremennyh preparatov dlja lechenija i profilaktiki ORVI i grippa // Rus. med. zhurn. – 2016; 3: 1–6.
  14. Mathie R., Frye J., Fisher P. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness // Cochrane Database Syst. Rev. – 2015; 1: CD001957.
  15. Kovalenko L.P., Tollerova A.V., Kuzntsova O.S. i dr. Eksperimental'noe izuchenie allergizirujuschih svojstv i immunotoksichnosti preparata Otsillokoktsinum // Toksikol. vestn. – 2015; 1 (130): 37–41.
  16. Shishkova V.N. Bezopasnaja terapija osteoartroza u patsientov s soputstvujuschimi zabolevanijami // Vrach. – 2016; 9: 64–9.
  17. Geppe N.A., Krylova N.A., Tjurina E.N. i dr. Napravlenie sovershenstvovanija terapii ORVI u detej // Doktor.Ru. – 2016; 6 (123): 47–51.
  18. Egorov V.I., Kozarenko A.V. Sovremennyj podhod k lecheniju ostryh virusnyh rinosinusitov // Al'manah klinicheskoj meditsiny. – 2016; 44 (7): pril. XXIV.
  19. Gomeopatija v XXI veke: vozmozhnosti i perspektivy // Meditsinskij sovet. – 2016; 16: 38–42.